Umut Yılmaz

9PUBLICATIONS
110CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical mycologyAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 27, 2026
Real-World Outcomes of Belinostat in Relapsed Refractory T-Cell Lymphomas: A Report from the Lymphoma Study Group of Turkish Society of Hematology.

|Dec 30, 2025
Exploring an independent association between rituximab-cyclophosphamide-doxorubicin-vincristine-prednisolone dose intensity and clinical outcomes in large B-cell lymphoma: Analyses of subsequent endpoints following a complete response in a real-world cohort of 1369 patients.

Umut Yılmaz, Mehmet Sinan Dal, Turgay Ulaş

|Jun 17, 2025
Simplified Molecular International Prognostic Index as an eligibility criterion for clinical trials: Analysis of the Turkish Lymphoma Study Group's large B-cell lymphoma cohort.

Umut Yılmaz, Esra Terzi Demirsoy, Fatma Keklik Karadağ

|Feb 11, 2025
Retrospective Study to Compare Outcomes in 159 Patients Undergoing First Autologous Stem Cell Transplantation for Myeloma Treated with Melphalan 140 mg/m² or 200 mg/m².

Umut Yılmaz, Şükran Erdem Nurcan, Deniz Özmen

|Nov 17, 2023
Does discontinuing bleomycin due to toxicity increase the risk of lymphoma progression? Real-life data from a homogeneous population of advanced stage Hodgkin lymphoma.

Umut Yılmaz, Güldane Zulfaliyeva, Adnan Nuri Güzelli

|Jan 26, 2023
Acquired Hemophilia A In Adults: A Multicenter Study from Turkey.

Eren Arslan Davulcu, Zühal Demirci, Umut Yılmaz

Pageof 2

Frequent Collaborators

3 joint publications

Muhlis Cem Ar

2 joint publications

Volkan Karakus

2 joint publications

Fahir Ozkalemkas

2 joint publications

Huseyin Saffet Bekoz